- UroToday Home
- Recent Abstracts
- Urologic Oncology
- Prostate Cancer
Conferences
SUO 2013 - Session Highlights: How does FDA approval of a device differ from the approval of a drug?
December 6, 2013
SUO 2013 - Session Highlights: Mechanism of castration resistance
December 6, 2013
SUO 2013 - Session Highlights: Human papillomavirus in penile cancer: Rationale and feasibility for prevention
December 6, 2013
SUO 2013 - Session Highlights: Insights into molecular pathways associated with penile cancer progression
December 6, 2013
SUO 2013 - Session Highlights: Biomarkers: What is the evidence they are useful in selecting/monitoring the active surveillance (AS) patient?
December 6, 2013
SUO 2013 - Session Highlights: Genomic markers in bladder cancer
December 6, 2013
SUO 2013 - Session Highlights: Patient selection and monitoring
December 6, 2013
SUO 2013 - Session Highlights: Translational science in urothelial cancers: TCGA update
December 5, 2013
SUO 2013 - Session Highlights: Kidney SPORE hot topic: If VEGF inhibition is so great, why do RCC patients still die?
December 5, 2013
SUO 2013 - Session Highlights: Evolution of the bladder cancer genome from occult field effects
December 5, 2013
SUO 2013 - Session Highlights: PD-1 pathway blockade in renal cell carcinoma: Hype or a new standard therapy?
December 5, 2013
SUO 2013 - Session Highlights: Translational research in renal cancer: New insights, future directions
December 5, 2013
SUO 2013 - Session Highlights: SPOREs Meeting - Wrap Up
December 5, 2013
SUO 2013 - Session Highlights: Tests after a positive biopsy
December 5, 2013
SUO 2013 - Session Highlights: Tests after a negative biopsy
December 5, 2013